Cargando…
Metabolic Reprogramming and Renal Fibrosis
There are several causes of chronic kidney disease, but all of these patients have renal fibrosis. Although many studies have examined the pathogenesis of renal fibrosis, there are still no effective treatments. A healthy and balanced metabolism is necessary for normal cell growth, proliferation, an...
Autores principales: | Zhu, Xiaoyu, Jiang, Lili, Long, Mengtuan, Wei, Xuejiao, Hou, Yue, Du, Yujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630632/ https://www.ncbi.nlm.nih.gov/pubmed/34859009 http://dx.doi.org/10.3389/fmed.2021.746920 |
Ejemplares similares
-
Molecular mechanisms underlying the role of hypoxia-inducible factor-1 α in metabolic reprogramming in renal fibrosis
por: Wei, Xuejiao, et al.
Publicado: (2022) -
Roxadustat: Not just for anemia
por: Zhu, Xiaoyu, et al.
Publicado: (2022) -
Advances in Understanding the Effects of Erythropoietin on Renal Fibrosis
por: Zhang, Yangyang, et al.
Publicado: (2020) -
Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases
por: Miao, Changxiu, et al.
Publicado: (2022) -
Metabolic Reprogramming of Liver Fibrosis
por: Delgado, M. Eugenia, et al.
Publicado: (2021)